• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低脂肪组织指数作为经颈静脉肝内门体分流术后肝硬化患者肝性脑病的一个指标。

Low adipose tissue index as an indicator of hepatic encephalopathy in cirrhotic patients following transjugular intrahepatic portosystemic shunt.

作者信息

Wang Chuhan, Teng Yue, Gao Jin, Zhang Zichen, Li Yonggang

机构信息

Department of Radiology, The First Affiliated Hospital of Soochow University, Suzhou, 215000, Jiangsu, People's Republic of China.

State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection, Medical College of Soochow University, Suzhou, 215123, China.

出版信息

Abdom Radiol (NY). 2023 Apr;48(4):1454-1467. doi: 10.1007/s00261-023-03813-4. Epub 2023 Feb 3.

DOI:10.1007/s00261-023-03813-4
PMID:36735033
Abstract

PURPOSE

We aimed to investigate the predictive value of body compositions measured by CT, including skeletal muscle and adipose tissue, for hepatic encephalopathy (HE) in cirrhotic patients following transjugular intrahepatic portosystemic shunt (TIPS).

METHODS

Patients who underwent TIPS between November 2015 and April 2021 were included in this retrospective study. CT images taken at L3 were quantified for three body composition indexes (cm/m), visceral fat area index (VFAI), subcutaneous fat area index (SFAI), and skeletal muscle index (SMI) at baseline. Multivariable logistic regression models were conducted to assess associations between post-TIPS HE and body compositions. Nomograms based on the multivariable logistic regression models were developed and were evaluated from Calibration curves.

RESULTS

Male patients had greater SMI, whereas SFAI and VFAI were higher in females (p < 0.001 for each). In sex stratified multivariate analyses after adjustment for other confounding variables, VFAI in males (p = 0.033) and SFAI in females (p = 0.003) were significant predictors of post-TIPS HE. Male patients with low VFAI (< 53.52 cm/m) (OR 6.44; 95% CI 1.72-23.59; p = 0.006) and female patients with low SFAI (< 70.05 cm/m) (OR 10.55; 95% CI 2.36-46.23; p = 0.002) had a higher risk of post-TIPS HE. Risk factors in the nomogram contributing to the male model included age, height, Child-Pugh score, and low VFAI; pre-albumin and low SFAI were contributed to female model.

CONCLUSION

Body compositions could not only be noninvasively used for nutritional assessment, but also be utilized to predict HE risk of cirrhotic patients after TIPS.

摘要

目的

我们旨在研究通过CT测量的身体成分,包括骨骼肌和脂肪组织,对经颈静脉肝内门体分流术(TIPS)后肝硬化患者肝性脑病(HE)的预测价值。

方法

本回顾性研究纳入了2015年11月至2021年4月期间接受TIPS的患者。在基线时,对L3水平的CT图像进行量化,以获取三个身体成分指标(厘米/米),即内脏脂肪面积指数(VFAI)、皮下脂肪面积指数(SFAI)和骨骼肌指数(SMI)。采用多变量逻辑回归模型评估TIPS后HE与身体成分之间的关联。基于多变量逻辑回归模型绘制列线图,并通过校准曲线进行评估。

结果

男性患者的SMI更高,而女性患者的SFAI和VFAI更高(每项p < 0.001)。在对其他混杂变量进行调整后的性别分层多变量分析中,男性的VFAI(p = 0.033)和女性的SFAI(p = 0.003)是TIPS后HE的显著预测因素。VFAI低(< 53.52厘米/米)的男性患者(OR 6.44;95% CI 1.72 - 23.59;p = 0.006)和SFAI低(< 70.05厘米/米)的女性患者(OR 10.55;95% CI 2.36 - 46.23;p = 0.002)发生TIPS后HE的风险更高。列线图中对男性模型有影响的危险因素包括年龄、身高、Child-Pugh评分和低VFAI;前白蛋白和低SFAI对女性模型有影响。

结论

身体成分不仅可用于无创营养评估,还可用于预测肝硬化患者TIPS后发生HE的风险。

相似文献

1
Low adipose tissue index as an indicator of hepatic encephalopathy in cirrhotic patients following transjugular intrahepatic portosystemic shunt.低脂肪组织指数作为经颈静脉肝内门体分流术后肝硬化患者肝性脑病的一个指标。
Abdom Radiol (NY). 2023 Apr;48(4):1454-1467. doi: 10.1007/s00261-023-03813-4. Epub 2023 Feb 3.
2
Prediction of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt Based on CT Radiomic Features of Visceral Adipose Tissue.基于内脏脂肪组织 CT 放射组学特征预测经颈静脉肝内门体分流术后肝性脑病。
Acad Radiol. 2024 May;31(5):1849-1861. doi: 10.1016/j.acra.2023.10.013. Epub 2023 Nov 24.
3
Post-transjugular Intrahepatic Portosystemic Shunt Hepatic Encephalopathy: Sarcopenia Adds Insult to Injury.经颈静脉肝内门体分流术相关肝性脑病:肌肉减少症雪上加霜。
Turk J Gastroenterol. 2023 Apr;34(4):406-412. doi: 10.5152/tjg.2023.21964.
4
A nomogram to predict the risk of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in Cirrhotic Patients.用于预测肝硬化患者经颈静脉肝内门体分流术后肝性脑病风险的列线图。
Sci Rep. 2020 Jun 10;10(1):9381. doi: 10.1038/s41598-020-65227-2.
5
Controlling nutritional status score as a new indicator of overt hepatic encephalopathy in cirrhotic patients following transjugular intrahepatic portosystemic shunt.经颈静脉肝内门体分流术后肝硬化患者显性肝性脑病新指标:营养状态评分。
Clin Nutr. 2022 Feb;41(2):560-566. doi: 10.1016/j.clnu.2021.12.036. Epub 2022 Jan 4.
6
The improvement in body composition including subcutaneous and visceral fat reduces ammonia and hepatic encephalopathy after transjugular intrahepatic portosystemic shunt.体成分(包括皮下和内脏脂肪)的改善可降低经颈静脉肝内门体分流术后的氨和肝性脑病。
Liver Int. 2021 Dec;41(12):2965-2973. doi: 10.1111/liv.15060. Epub 2021 Sep 28.
7
Prediction of Mortality and Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt Placement: Baseline and Longitudinal Body Composition Measurement.经颈静脉肝内门体分流术放置后死亡率和肝性脑病的预测:基线和纵向身体成分测量。
J Vasc Interv Radiol. 2024 May;35(5):648-657.e1. doi: 10.1016/j.jvir.2024.01.012. Epub 2024 Jan 18.
8
Contributory roles of sarcopenia and myosteatosis in development of overt hepatic encephalopathy and mortality after transjugular intrahepatic portosystemic shunt.肌肉减少症和肌内脂肪变性在经颈静脉肝内门体分流术后显性肝性脑病发展和死亡率中的作用。
World J Gastroenterol. 2023 May 14;29(18):2875-2887. doi: 10.3748/wjg.v29.i18.2875.
9
Predicting disease progression in cirrhotic patients after transjugular intrahepatic portosystemic shunt implantation: A sex-stratified analysis.经颈静脉肝内门体分流术植入后肝硬化患者疾病进展的预测:一项性别分层分析。
World J Gastroenterol. 2023 Nov 14;29(42):5768-5780. doi: 10.3748/wjg.v29.i42.5768.
10
Impact of nutritional status on the outcome of transjugular intrahepatic portosystemic shunt in patients with cirrhosis: a systematic review.营养状况对肝硬化患者经颈静脉肝内门体分流术治疗结局的影响:系统评价。
Br J Radiol. 2024 Feb 2;97(1154):331-340. doi: 10.1093/bjr/tqad065.

引用本文的文献

1
Role of Nutrition in the Management of Chronic Liver Disease.营养在慢性肝病管理中的作用。
Gastro Hep Adv. 2025 Jan 2;4(5):100613. doi: 10.1016/j.gastha.2024.100613. eCollection 2025.
2
Hepatic encephalopathy post-TIPS: Current status and prospects in predictive assessment.经颈静脉肝内门体分流术后肝性脑病:预测评估的现状与前景
Comput Struct Biotechnol J. 2024 Jul 10;24:493-506. doi: 10.1016/j.csbj.2024.07.008. eCollection 2024 Dec.
3
Post-Transjugular Intrahepatic Portosystemic Shunt (TIPS) Hepatic Encephalopathy-A Review of the Past Decade's Literature Focusing on Incidence, Risk Factors, and Prophylaxis.

本文引用的文献

1
Sarcopenia in Patients with Cirrhosis after Transjugular Intrahepatic Portosystemic Shunt Placement.肝硬化经颈静脉肝内门体分流术患者的肌肉减少症。
Radiology. 2022 Jun;303(3):711-719. doi: 10.1148/radiol.211172. Epub 2022 Mar 15.
2
Validation of a standardized CT protocol for the evaluation of varices and porto-systemic shunts in cirrhotic patients.肝硬化患者静脉曲张和门体分流的评估的标准化 CT 方案的验证。
Eur J Radiol. 2022 Feb;147:110010. doi: 10.1016/j.ejrad.2021.110010. Epub 2021 Oct 30.
3
The improvement in body composition including subcutaneous and visceral fat reduces ammonia and hepatic encephalopathy after transjugular intrahepatic portosystemic shunt.
经颈静脉肝内门体分流术(TIPS)相关性肝性脑病——基于发病率、危险因素及预防的过去十年文献综述
J Clin Med. 2023 Dec 19;13(1):14. doi: 10.3390/jcm13010014.
4
Transjugular Intrahepatic Portosystemic Shunt Placement: Effects on Nutritional Status in Cirrhotic Patients.经颈静脉肝内门体分流术的置入:对肝硬化患者营养状况的影响
J Clin Med. 2023 Nov 10;12(22):7029. doi: 10.3390/jcm12227029.
体成分(包括皮下和内脏脂肪)的改善可降低经颈静脉肝内门体分流术后的氨和肝性脑病。
Liver Int. 2021 Dec;41(12):2965-2973. doi: 10.1111/liv.15060. Epub 2021 Sep 28.
4
Sarcopenia as a prognostic predictor of liver cirrhosis: a multicentre study in China.肌肉减少症作为肝硬化预后预测因子的研究:中国多中心研究。
J Cachexia Sarcopenia Muscle. 2021 Dec;12(6):1948-1958. doi: 10.1002/jcsm.12797. Epub 2021 Sep 14.
5
Human adipose and skeletal muscle tissue DNA, RNA, and protein content.人体脂肪和骨骼肌肉组织的 DNA、RNA 和蛋白质含量。
J Appl Physiol (1985). 2021 Oct 1;131(4):1370-1379. doi: 10.1152/japplphysiol.00343.2021. Epub 2021 Aug 26.
6
Pathophysiology and Management of Variceal Bleeding.食管胃静脉曲张出血的病理生理学与处理。
Drugs. 2021 Apr;81(6):647-667. doi: 10.1007/s40265-021-01493-2. Epub 2021 Mar 12.
7
Risk Prediction Models for Post-Operative Mortality in Patients With Cirrhosis.肝硬化患者术后死亡率的风险预测模型。
Hepatology. 2021 Jan;73(1):204-218. doi: 10.1002/hep.31558. Epub 2020 Dec 10.
8
A Sex-Stratified Prognostic Nomogram Incorporating Body Compositions for Long-Term Mortality in Cirrhosis.纳入身体成分的性别分层预后列线图用于预测肝硬化患者的长期死亡率。
JPEN J Parenter Enteral Nutr. 2021 Feb;45(2):403-413. doi: 10.1002/jpen.1841. Epub 2020 May 2.
9
Body composition predicts mortality and decompensation in compensated cirrhosis patients: A prospective cohort study.身体成分可预测代偿期肝硬化患者的死亡率和失代偿情况:一项前瞻性队列研究。
JHEP Rep. 2019 Dec 5;2(1):100061. doi: 10.1016/j.jhepr.2019.11.005. eCollection 2020 Feb.
10
Sarcopenia Is Associated With Development of Acute-on-Chronic Liver Failure in Decompensated Liver Cirrhosis Receiving Transjugular Intrahepatic Portosystemic Shunt.肌肉减少症与接受经颈静脉肝内门体分流术的失代偿期肝硬化发生慢加急性肝衰竭相关。
Clin Transl Gastroenterol. 2019 Apr;10(4):e00025. doi: 10.14309/ctg.0000000000000025.